联合11C-PiB PET/CT与99mTc-DPD闪烁显像提升心脏淀粉样变的诊断与预后评估
本研究回顾性纳入50例临床疑似心脏淀粉样变患者,评估11C-PiB PET/CT与99mTc-DPD闪烁显像联合应用的诊断效能。联合影像对AL与ATTR亚型鉴别具互补优势,机器学习模型鉴别亚型AUC达0.94(95%CI 0.93-0.95);基于预测生存的总生存分层显著(p值=0.006;校正HR 2.43 [95%CI 1.03-5.71])。
要点
- 联合11C-PiB PET/CT与99mTc-DPD闪烁显像可提升心脏淀粉样变诊断准确性。
- 机器学习模型鉴别AL与ATTR亚型AUC为0.94(95%CI 0.93-0.95)。
- 基于预测生存的总生存分层显著(p值=0.006;校正HR 2.43 [95%CI 1.03-5.71])。
核心结论
- 整合11C-PiB PET/CT与99mTc-DPD闪烁显像并辅以机器学习和基于规则的模型,可提升心脏淀粉样变的诊断准确性与预后评估。
研究设计与样本
- 回顾性评估50例临床疑似心脏淀粉样变患者中联合11C-PiB PET/CT与99mTc-DPD闪烁显像的诊断效能,并以活检结果或基因检测为诊断参照。
主要发现
- 联合影像方法显著提高诊断准确性,11C-PiB PET与99mTc-DPD闪烁显像分别在检测AL与ATTR方面显示互补优势。
- 机器学习模型鉴别心脏淀粉样变亚型的AUC为0.94(95%CI 0.93-0.95)。
- 基于规则的模型诊断ATTR的AUC为0.95(95%CI 0.88-1.00),诊断AL的AUC为0.88(95%CI 0.770-0.961)。
- 基于预测生存的总生存分层显著(p值=0.006;校正HR 2.43 [95%CI 1.03-5.71])。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac amyloidosis (CA) is a severe condition characterized by amyloid fibril deposition in the myocardium, leading to restrictive cardiomyopathy and heart failure. Differentiating between amyloidosis subtypes is crucial due to distinct treatment strategies. The individual conventional diagnostic methods lack the accuracy needed for effective subtype identification. This study aimed to evaluate the efficacy of combining 11C-PiB PET/CT and 99mTc-DPD scintigraphy in detecting CA and distinguishing between its main subtypes, light chain (AL) and transthyretin (ATTR) amyloidosis while assessing the association of imaging findings with patient prognosis. METHODS: We retrospectively evaluated the diagnostic efficacy of combining 11C-PiB PET/CT and 99mTc-DPD scintigraphy in a cohort of 50 patients with clinical suspicion of CA. Semi-quantitative imaging markers were extracted from the images. Diagnostic performance was calculated against biopsy results or genetic testing. Both machine learning models and a rationale-based model were developed to detect CA and classify subtypes. Survival prediction over five years was assessed using a random survival forest model. Prognostic value was assessed using Kaplan-Meier estimators and Cox proportional hazards models. RESULTS: The combined imaging approach significantly improved diagnostic accuracy, with 11C-PiB PET and 99mTc-DPD scintigraphy showing complementary strengths in detecting AL and ATTR, respectively. The machine learning model achieved an AUC of 0.94 (95% CI 0.93-0.95) for CA subtype differentiation, while the rationale-based model demonstrated strong diagnostic ability with AUCs of 0.95 (95% CI 0.88-1.00) for ATTR and 0.88 (95% CI 0.770-0.961) for AL. Survival prediction models identified key prognostic markers, with significant stratification of overall mortality based on predicted survival (p value = 0.006; adj HR 2.43 [95% CI 1.03-5.71]). CONCLUSION: The integration of 11C-PiB PET/CT and 99mTc-DPD scintigraphy, supported by both machine learning and rationale-based models, enhances the diagnostic accuracy and prognostic assessment of cardiac amyloidosis, with significant implications for clinical practice.
引用
- Hong Z, Spielvogel CP, Xue S, et al. Enhanced diagnostic and prognostic assessment of cardiac amyloidosis using combined 11C-PiB PET/CT and 99mTc-DPD scintigraphy. Eur J Nucl Med Mol Imaging. 2025. PMID: 40019577. doi:10.1007/s00259-025-07157-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。